Cleary, Davis Polk Lead Diabetes Biz MiniMed's $560M IPO
Medtronic's diabetes-focused spin-off MiniMed Group began trading publicly Friday after pricing a $560 million initial public offering, well below the expected target of $742 million....To view the full article, register now.
Already a subscriber? Click here to view full article